Scrip interview with Piers Ingram, CEO of Hummingbird Bioscience

Scrip interview with Piers Ingram, CEO of Hummingbird Bioscience

Pharma Intelligence’s Insights speaks to Hummingbird CEO Piers Ingram following the Singapore-based company’s Series C financing round.